Mode
Text Size
Log in / Sign up

Inflammatory indices associated with increased chronic kidney disease risk in coronary artery disease cohort.

Inflammatory indices associated with increased chronic kidney disease risk in coronary artery diseas…
Photo by Vitaly Gariev / Unsplash
Key Takeaway
Consider AISI thresholds for CKD risk stratification in coronary artery disease, noting observational evidence limits causality.

This cohort study included 5181 patients with coronary artery disease across three centers. The investigation focused on the association between composite inflammatory indices and the development of chronic kidney disease within this population. Follow-up duration was described as long-term, though specific timeframes were not reported.

Exposure included aggregate index of systemic inflammation (AISI), systemic inflammatory response index (SIRI), systemic immune-inflammation index (SII), and platelet-to-lymphocyte ratio (PLR). All four inflammatory markers were significantly associated with an increased risk of chronic kidney disease. Risk thresholds identified at AISI >115, SIRI >0.96, SII >458, and PLR >123. AISI showed the best predictive performance among the indices evaluated.

Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported in the provided evidence. The study design does not establish causality, and limitations were not explicitly detailed in the source documentation. Funding or conflicts of interest were also not reported.

Practice relevance suggests AISI may serve as a useful indicator for early risk stratification and clinical management of chronic kidney disease in patients with coronary artery disease.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundCoronary artery disease (CAD) is associated with persistent inflammation, which plays an important role in the development of renal dysfunction. This study investigated the association between composite inflammatory indices and the long-term risk of chronic kidney disease (CKD) in patients with CAD, and further aimed to identify the inflammatory marker with the best predictive performance.MethodsWe included 5181 patients with CAD from three centers. Multivariable-adjusted Cox regression models and cumulative risk curves (CRC) were used to evaluate the associations between four composite inflammatory markers—aggregate index of systemic inflammation (AISI), systemic inflammatory response index (SIRI), systemic immune-inflammation index (SII), and platelet-to-lymphocyte ratio (PLR)—and CKD risk. Restricted cubic splines (RCS) were applied to examine dose-response relationships, while predictive performance was compared using receiver operating characteristic (ROC) analysis, the C-index, and random forest (RF) variable importance.ResultsMultivariable Cox regression showed that all four inflammatory markers were significantly associated with an increased risk of CKD, and these findings were further supported by CRC analysis. RCS analysis demonstrated clear dose-response relationships, with risk thresholds identified at AISI >115, SIRI >0.96, SII >458, and PLR >123. Among all markers, AISI showed the best predictive performance according to the combined evaluation of ROC analysis, the C-index, and RF variable importance.ConclusionElevated inflammatory marker levels were significantly associated with a higher risk of CKD in patients with CAD. Among the markers evaluated, AISI demonstrated the strongest predictive value and may serve as a useful indicator for early risk stratification and clinical management of CKD in this population.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.